129 related articles for article (PubMed ID: 37058562)
1. M2 macrophages drive leukemic transformation by imposing resistance to phagocytosis and improving mitochondrial metabolism.
Weinhäuser I; Pereira-Martins DA; Almeida LY; Hilberink JR; Silveira DRA; Quek L; Ortiz C; Araujo CL; Bianco TM; Lucena-Araujo A; Mota JM; Hogeling SM; Sternadt D; Visser N; Diepstra A; Ammatuna E; Huls G; Rego EM; Schuringa JJ
Sci Adv; 2023 Apr; 9(15):eadf8522. PubMed ID: 37058562
[TBL] [Abstract][Full Text] [Related]
2. Taking the STING out of acute myeloid leukemia through macrophage-mediated phagocytosis.
Dalton WB; Ghiaur G; Resar LM
J Clin Invest; 2022 Mar; 132(5):. PubMed ID: 35229728
[TBL] [Abstract][Full Text] [Related]
3. TIGIT blockade repolarizes AML-associated TIGIT
Brauneck F; Fischer B; Witt M; Muschhammer J; Oelrich J; da Costa Avelar PH; Tsoka S; Bullinger L; Seubert E; Smit DJ; Bokemeyer C; Ackermann C; Wellbrock J; Haag F; Fiedler W
J Immunother Cancer; 2022 Dec; 10(12):. PubMed ID: 36549780
[TBL] [Abstract][Full Text] [Related]
4. Knockdown of let-7b in leukemia associated macrophages inhibit acute myeloid leukemia progression.
Tian C; Li Y; Si J; Kang J; Chen Z; Nuermaimaiti R; Wang Y; Yu Y; Zhao Z; Wang X; Zhang Y; Zhao H; Yang H; You MJ; Zheng G; Wang L
Hematol Oncol; 2023 Aug; 41(3):510-519. PubMed ID: 36579468
[TBL] [Abstract][Full Text] [Related]
5. Leukemic blasts program bone marrow adipocytes to generate a protumoral microenvironment.
Shafat MS; Oellerich T; Mohr S; Robinson SD; Edwards DR; Marlein CR; Piddock RE; Fenech M; Zaitseva L; Abdul-Aziz A; Turner J; Watkins JA; Lawes M; Bowles KM; Rushworth SA
Blood; 2017 Mar; 129(10):1320-1332. PubMed ID: 28049638
[TBL] [Abstract][Full Text] [Related]
6. MiR-451a enhances the phagocytosis and affects both M1 and M2 polarization in macrophages.
Liu X; Zhang D; Wang H; Ren Q; Li B; Wang L; Zheng G
Cell Immunol; 2021 Jul; 365():104377. PubMed ID: 34004369
[TBL] [Abstract][Full Text] [Related]
7. CYLD stimulates macrophage phagocytosis of leukemic cells through STAT1 signalling in acute myeloid leukemia.
Huyen NT; Ngoc NT; Giang NH; Trang DT; Hanh HH; Binh VD; Giang NV; Canh NX; Xuan NT
PLoS One; 2023; 18(8):e0283586. PubMed ID: 37549179
[TBL] [Abstract][Full Text] [Related]
8. LC3-associated phagocytosis in bone marrow macrophages suppresses acute myeloid leukemia progression through STING activation.
Moore JA; Mistry JJ; Hellmich C; Horton RH; Wojtowicz EE; Jibril A; Jefferson M; Wileman T; Beraza N; Bowles KM; Rushworth SA
J Clin Invest; 2022 Mar; 132(5):. PubMed ID: 34990402
[TBL] [Abstract][Full Text] [Related]
9. Anti-CD47 Treatment Stimulates Phagocytosis of Glioblastoma by M1 and M2 Polarized Macrophages and Promotes M1 Polarized Macrophages In Vivo.
Zhang M; Hutter G; Kahn SA; Azad TD; Gholamin S; Xu CY; Liu J; Achrol AS; Richard C; Sommerkamp P; Schoen MK; McCracken MN; Majeti R; Weissman I; Mitra SS; Cheshier SH
PLoS One; 2016; 11(4):e0153550. PubMed ID: 27092773
[TBL] [Abstract][Full Text] [Related]
10. Peritoneal resident macrophages in mice with MLL-AF9-induced acute myeloid leukemia show an M2-like phenotype.
Chen C; Wang R; Feng W; Yang F; Wang L; Yang X; Ren L; Zheng G
Ann Transl Med; 2021 Feb; 9(3):266. PubMed ID: 33708893
[TBL] [Abstract][Full Text] [Related]
11. Relationship between tumor-associated macrophage subsets and CD47 expression in squamous cell carcinoma of the head and neck in the tumor microenvironment.
Sakakura K; Takahashi H; Kaira K; Toyoda M; Murata T; Ohnishi H; Oyama T; Chikamatsu K
Lab Invest; 2016 Sep; 96(9):994-1003. PubMed ID: 27322955
[TBL] [Abstract][Full Text] [Related]
12. Blast cells surviving acute myeloid leukemia induction therapy are in cycle with a signature of FOXM1 activity.
Williams MS; Basma NJ; Amaral FMR; Wiseman DH; Somervaille TCP
BMC Cancer; 2021 Oct; 21(1):1153. PubMed ID: 34711181
[TBL] [Abstract][Full Text] [Related]
13. CD117/CD34 expression in leukemic blasts.
Wells SJ; Bray RA; Stempora LL; Farhi DC
Am J Clin Pathol; 1996 Aug; 106(2):192-5. PubMed ID: 8712172
[TBL] [Abstract][Full Text] [Related]
14. The efficient generation of immunocompetent dendritic cells from leukemic blasts in acute myeloid leukemia: a local experience.
Bagheri K; Alimoghadam K; Pourfathollah AA; Hassan ZM; Hajati J; Moazzeni SM
Pathol Oncol Res; 2009 Jun; 15(2):257-67. PubMed ID: 18807213
[TBL] [Abstract][Full Text] [Related]
15. Hemophagocytosis by leukemic blasts in 7 acute myeloid leukemia cases with t(16;21)(p11;q22): common morphologic characteristics for this type of leukemia.
Imashuku S; Hibi S; Sako M; Lin YW; Ikuta K; Nakata Y; Mori T; Iizuka S; Horibe K; Tsunematsu Y
Cancer; 2000 Apr; 88(8):1970-5. PubMed ID: 10760776
[TBL] [Abstract][Full Text] [Related]
16. Class II-associated invariant chain peptide down-modulation enhances the immunogenicity of myeloid leukemic blasts resulting in increased CD4+ T-cell responses.
van Luijn MM; Chamuleau ME; Thompson JA; Ostrand-Rosenberg S; Westers TM; Souwer Y; Ossenkoppele GJ; van Ham SM; van de Loosdrecht AA
Haematologica; 2010 Mar; 95(3):485-93. PubMed ID: 19903675
[TBL] [Abstract][Full Text] [Related]
17. Acute myeloid leukemia cells polarize macrophages towards a leukemia supporting state in a Growth factor independence 1 dependent manner.
Al-Matary YS; Botezatu L; Opalka B; Hönes JM; Lams RF; Thivakaran A; Schütte J; Köster R; Lennartz K; Schroeder T; Haas R; Dührsen U; Khandanpour C
Haematologica; 2016 Oct; 101(10):1216-1227. PubMed ID: 27390361
[TBL] [Abstract][Full Text] [Related]
18. Tumor Microenvironment in Acute Myeloid Leukemia: Adjusting Niches.
Menter T; Tzankov A
Front Immunol; 2022; 13():811144. PubMed ID: 35273598
[TBL] [Abstract][Full Text] [Related]
19. Dielectrophoretic Microfluidic Chip Enables Single-Cell Measurements for Multidrug Resistance in Heterogeneous Acute Myeloid Leukemia Patient Samples.
Khamenehfar A; Gandhi MK; Chen Y; Hogge DE; Li PC
Anal Chem; 2016 Jun; 88(11):5680-8. PubMed ID: 27149245
[TBL] [Abstract][Full Text] [Related]
20. A CXCR4 antagonist leads to tumor suppression by activation of immune cells in a leukemia-induced microenvironment.
Han AR; Lee JY; Kim HJ; Min WS; Park G; Kim SH
Oncol Rep; 2015 Dec; 34(6):2880-8. PubMed ID: 26398122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
